US$36.3 for Q3... not terrible but would have liked to see something closer to Q2 at 47.1.
Column 1 Column 2 Column 3 0 Axiron 1 Q1 US 38.3 2 Q1 Intl 1.2 3 Q1 Total 39.5 4 Q2 US 45.5 5 Q2 Intl 1.6 6 Q2 Total 47.1 7 Q3 US 34.5 8 Q3 Intl 1.8 9 Q3 Total 36.3 10 Q4 US 11 Q4 Intl 12 Q4 Total 13 2014 US 118.4 14 2014 Intl 4.5
https://investor.lilly.com/eventdetail.cfm?EventID=140768
US$36.3 for Q3... not terrible but would have liked to see...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.73M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 152642 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.12pm 04/09/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable